MD Atlas
Pricing
Sign in
Data last updated: Apr 2025
i-Tracker Anti-Ocrelizumab
353267CTO003AVA
On Market
IVDR Class B
Regulation
EU IVDR
Manufacturer
BIOSYNEX
Primary DI
03532672000219
Reference
CTO 003-50
Follow this device
Coming soon
View on EUDAMED
View manufacturer
Coming soon
Identification
Primary DI
03532672000219
Basic UDI-DI
353267CTO003AVA
Reference
CTO 003-50
Issuing Agency
—
ULID
2MXCV39T
Classification
Risk Class
IVDR Class B
Regulation
EU IVDR
Status
On Market
Device Types
Coming soon
Manufacturer
Manufacturer
BIOSYNEX
Manufacturer SRN
FR-MF-000042615
Manufacturer Status
Active
CND Nomenclature
V0599
CLINICAL PROCEDURES KITS NOT INCLUDED IN OTHER CLASSES - OTHER
Coming soon
Certificates
Coming soon
Related Devices
Market Presence
Market presence
NL
DE
FR
IT
Countries on market
Coming soon
i-Tracker Anti-Adalimumab Total Ab
On Market
i-Tracker Anti-Etanercept
On Market
i-Tracker Anti-Infliximab Total Ab
On Market
i-Tracker Anti-Risankizumab
On Market
i-Tracker Etanercept
On Market